Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”

Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A... Hindawi Case Reports in Oncological Medicine Volume 2019, Article ID 3868790, 1 page https://doi.org/10.1155/2019/3868790 Corrigendum Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience” 1 1 2 1 3 Vidhya Karivedu , Ihab Eldessouki , Zelia Correa, Ahmad Taftaf , Zheng Zhu , 4 5 Abouelmagd Makramalla, and Nagla Abdel Karim Department of Internal Medicine, Division of Hematology/Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA Ocular Oncology Service, Department of Ophthalmology, University of Cincinnati College of Medicine, USA Department of Biostatistics and Bioinformatics, Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, OH, USA Division of Vascular and Interventional Radiology, University of Cincinnati College of Medicine, Cincinnati, OH, USA Department of Internal Medicine, Division of Hematology/Oncology, Medical College of Georgia-Augusta University, Augusta, GA, USA Correspondence should be addressed to Vidhya Karivedu; kariveva@ucmail.uc.edu Received 28 July 2019; Accepted 23 August 2019; Published 28 October 2019 Copyright © 2019 Vidhya Karivedu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In the article titled “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience” [1], Dr. Zelia Correa was missing from the authors’ list. Dr. Zelia Correa commented on the article and referred the patient population in the study. The corrected authors’ list and affiliations are shown above. References [1] V. Karivedu, I. Eldessouki, A. Taftaf, Z. Zhu, A. Makramalla, and N. A. Karim, “Nivolumab and ipilimumab in the treatment of metastatic uveal melanoma: a single-center experience,” Case Reports in Oncological Medicine, vol. 2019, Article ID 3560640, 8 pages, 2019. MEDIATORS of INFLAMMATION The Scientific Gastroenterology Journal of World Journal Research and Practice Diabetes Research Disease Markers Hindawi Hindawi Publishing Corporation Hindawi Hindawi Hindawi Hindawi www.hindawi.com Volume 2018 http://www www.hindawi.com .hindawi.com V Volume 2018 olume 2013 www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 International Journal of Journal of Immunology Research Endocrinology Hindawi Hindawi www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 Submit your manuscripts at www.hindawi.com BioMed PPAR Research Research International Hindawi Hindawi www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 Journal of Obesity Evidence-Based Journal of Journal of Stem Cells Complementary and Ophthalmology International Alternative Medicine Oncology Hindawi Hindawi Hindawi Hindawi Hindawi www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 www.hindawi.com Volume 2013 Parkinson’s Disease Computational and Behavioural Mathematical Methods AIDS Oxidative Medicine and in Medicine Neurology Research and Treatment Cellular Longevity Hindawi Hindawi Hindawi Hindawi Hindawi www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Case Reports in Oncological Medicine Hindawi Publishing Corporation

Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”

Loading next page...
 
/lp/hindawi-publishing-corporation/corrigendum-to-nivolumab-and-ipilimumab-in-the-treatment-of-metastatic-xm0i9v7eu0

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Hindawi Publishing Corporation
Copyright
Copyright © 2019 Vidhya Karivedu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
ISSN
2090-6706
eISSN
2090-6714
DOI
10.1155/2019/3868790
Publisher site
See Article on Publisher Site

Abstract

Hindawi Case Reports in Oncological Medicine Volume 2019, Article ID 3868790, 1 page https://doi.org/10.1155/2019/3868790 Corrigendum Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience” 1 1 2 1 3 Vidhya Karivedu , Ihab Eldessouki , Zelia Correa, Ahmad Taftaf , Zheng Zhu , 4 5 Abouelmagd Makramalla, and Nagla Abdel Karim Department of Internal Medicine, Division of Hematology/Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA Ocular Oncology Service, Department of Ophthalmology, University of Cincinnati College of Medicine, USA Department of Biostatistics and Bioinformatics, Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, OH, USA Division of Vascular and Interventional Radiology, University of Cincinnati College of Medicine, Cincinnati, OH, USA Department of Internal Medicine, Division of Hematology/Oncology, Medical College of Georgia-Augusta University, Augusta, GA, USA Correspondence should be addressed to Vidhya Karivedu; kariveva@ucmail.uc.edu Received 28 July 2019; Accepted 23 August 2019; Published 28 October 2019 Copyright © 2019 Vidhya Karivedu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In the article titled “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience” [1], Dr. Zelia Correa was missing from the authors’ list. Dr. Zelia Correa commented on the article and referred the patient population in the study. The corrected authors’ list and affiliations are shown above. References [1] V. Karivedu, I. Eldessouki, A. Taftaf, Z. Zhu, A. Makramalla, and N. A. Karim, “Nivolumab and ipilimumab in the treatment of metastatic uveal melanoma: a single-center experience,” Case Reports in Oncological Medicine, vol. 2019, Article ID 3560640, 8 pages, 2019. MEDIATORS of INFLAMMATION The Scientific Gastroenterology Journal of World Journal Research and Practice Diabetes Research Disease Markers Hindawi Hindawi Publishing Corporation Hindawi Hindawi Hindawi Hindawi www.hindawi.com Volume 2018 http://www www.hindawi.com .hindawi.com V Volume 2018 olume 2013 www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 International Journal of Journal of Immunology Research Endocrinology Hindawi Hindawi www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 Submit your manuscripts at www.hindawi.com BioMed PPAR Research Research International Hindawi Hindawi www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 Journal of Obesity Evidence-Based Journal of Journal of Stem Cells Complementary and Ophthalmology International Alternative Medicine Oncology Hindawi Hindawi Hindawi Hindawi Hindawi www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 www.hindawi.com Volume 2013 Parkinson’s Disease Computational and Behavioural Mathematical Methods AIDS Oxidative Medicine and in Medicine Neurology Research and Treatment Cellular Longevity Hindawi Hindawi Hindawi Hindawi Hindawi www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 www.hindawi.com Volume 2018 www.hindawi.com Volume 2018

Journal

Case Reports in Oncological MedicineHindawi Publishing Corporation

Published: Oct 28, 2019

References